Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis

Published:2021-10-18 Issue:1 Volume:10 Page:97-105
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Pacheco-Soto Blanca T.¹,Elguezabal-Rodelo Rebeca Garazi¹,Porchia Leonardo M.²,Torres-Rasgado Enrique¹,Pérez-Fuentes Ricardo¹²,Gonzalez-Mejia M. Elba¹^ORCID

Affiliation:

1. Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico

2. Laboratorio de Fisiopatología en Enfermedades Crónicas, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Delegación Puebla, Puebla, Mexico

Funder

Programa para el Desarrollo Profesional Docente

Vicerrectorıa de Investigacion, Benemerita Universidad Autonoma de Puebla

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2021.1989194

Reference53 articles.

1. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

2. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass